Suscribirse

Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function - 05/09/11

Doi : 10.1016/S0002-9343(00)00330-2 
Jane Wardle, PhD a, , Peter Rogers, PhD b, Patricia Judd, PhD c, Moira A Taylor, PhD a, Lorna Rapoport, BSc a, Michael Green, PhD a, Kathryn Nicholson Perry, MSc a
a ICRF Health Behaviour Unit (JW, MT, LR, KNP), Department of Epidemiology and Public Health, University College London, London, United Kingdom 
b Institute of Food Research (PR, MG), Reading, London, United Kingdom 
c Department of Nutrition (PJ), Kings College London, London, United Kingdom 

*Requests for reprints should be addressed to Jane Wardle, PhD, Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, 2-16 Torrington Place, London WC1E 6BT, United Kingdom

Abstract

PURPOSE: Epidemiological studies have suggested that cholesterol lowering could affect psychological functioning. This study was designed to test whether cholesterol-lowering diets adversely affect mood and cognitive function.

SUBJECTS AND METHODS: We randomly assigned 176 adults with elevated serum cholesterol levels (>5.2 mM [198 mg/dL]) to either a low-fat diet, a Mediterranean diet, or a waiting-list control. Cholesterol levels, psychological well-being (depression, anxiety, hostility), and cognitive function were assessed at baseline, 6 weeks, and 12 weeks.

RESULTS: Total serum cholesterol levels fell significantly more in the intervention groups (8.2% reduction) than in the control group (P <0.001). All three groups showed a modest improvement in psychological well-being during the 12-week treatment period, but there were no differences among the groups. There were no between-group differences on three measures of cognitive function, but for a fourth measure, which involved the task with the greatest processing load, the two intervention groups did significantly worse (P <0.001) than the control group. The change in performance was correlated with the change in total serum cholesterol level (r = 0.21, P = 0.01).

CONCLUSIONS: Two dietary interventions that successfully lowered serum cholesterol levels had no adverse effect on mood. There was some evidence for a relative impairment in cognitive function in the treated groups in one of four cognitive tests, but additional studies will be required to determine the relevance of this finding.

El texto completo de este artículo está disponible en PDF.

Esquema


 Supported by a grant from the Biotechnology and Biological Sciences Research Council.


© 2000  Excerpta Medica Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 108 - N° 7

P. 547-553 - mai 2000 Regresar al número
Artículo precedente Artículo precedente
  • Effects of lovastatin on cognitive function and psychological well-being
  • Matthew F Muldoon, Steven D Barger, Christopher M Ryan, Janine D Flory, John P Lehoczky, Karen A Matthews, Stephen B Manuck
| Artículo siguiente Artículo siguiente
  • Autoantibodies against platelet glycoproteins in critically ill patients with thrombocytopenia
  • François Stéphan, Mohamed Ali Cheffi, Cécile Kaplan, Jean-Michel Maillet, Ana Novara, Jean-Yves Fagon, Francis Bonnet

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.